Source: Melton ST, Kirkwood
CK. Anxiety Disorders I: Generalized Anxiety, Panic, and Social
Anxiety Disorders. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR,
Wells BG, Posey LM, eds. Pharmacotherapy:
A Pathophysiologic Approach. 8th ed. http://accesspharmacy.com/content.aspx?aid=7989670.
Accessed May 25, 2012.
- Anxiety, apprehension, or worry not linked to a specific
cause or situation. Symptoms severe enough to impair functioning.
- Combination of vulnerability (e.g., genetic predisposition,
childhood adversity) and stress (e.g., occupational, traumatic experience).
- Noradrenergic model: Autonomic nervous system hypersensitive
and overreacts to various stimuli. Chronic noradrenergic overactivity
- γ-Aminobutyric acid (GABA) receptor model:
Underactivity of GABA systems or downregulated central benzodiazepine
receptors. Reduced benzodiazepine binding in the left temporal lobe.
- 5-HT model: Excessive 5-HT transmission or overactivity
of stimulatory 5-HT pathways.
- One-year prevalence rate is 2.7%.
- More common in women, persons with social issues, and those
with a family history of anxiety and depression.
- Childhood trauma
- Stressful lifestyle
- Chronic medical illness
- Physical disability
- Other psychiatric disorders (schizophrenia, dementia)
- Alcohol, nicotine, caffeine use
- Medications (e.g., sympathomimetics, thyroid hormones,
- Psychologic and cognitive symptoms:
- Worries difficult to control
- Feeling keyed up or on edge
- Poor concentration or mind going blank
- Physical symptoms:
- Muscle tension
- Sleep disturbance
- Social, occupational, or other
important functional areas
- Poor coping skills
- Gradual onset at mean age of 21 years.
- Course is chronic, with multiple spontaneous exacerbations
and remissions. High relapse percentage and low recovery rate.
Means of Confirmation
- Perform complete physical and mental status examination;
appropriate laboratory tests; and medical, psychiatric, and drug
- Symptoms may be associated with medical illnesses or drug
- Anxiety may occur in psychiatric illnesses (e.g., mood disorders,
schizophrenia, substance withdrawal).
- Diagnostic criteria require persistent symptoms most days
for at least 6 months; anxiety or worry must be about multiple matters
and accompanied by at least three psychologic or physiologic symptoms.
- Reduce severity, duration, and frequency of symptoms and
- Minimize symptoms or functional impairment and improve quality
of life long term.
- Psychotherapy, short-term counseling, stress management,
cognitive therapy, meditation, supportive therapy, exercise
- Cognitive behavioral therapy (CBT) is most effective option,
used alone or in combination with antianxiety drugs.
- Educate patients to avoid caffeine, stimulants, excessive
alcohol, and diet pills.
- Drug choices (Table 1):
- First line: Duloxetine,
escitalopram, paroxetine, sertraline, venlafaxine XR
- Second line: Benzodiazepines, buspirone, imipramine
- Alternatives: Hydroxyzine, pregabalin, quetiapine
- All equally effective; most
of improvement occurs in first 2 weeks of therapy. More effective
for somatic and autonomic symptoms; antidepressants more effective
for psychic symptoms (apprehension, worry).
- Start with low doses, adjusting weekly.
- Treat acute anxiety for up to 4 weeks; manage persistent symptoms
- May dose long half-life drugs once daily at bedtime ...
Log In to View More
If you don't have a subscription, please view our individual subscription options below to find out how you can gain access to this content.
Want remote access to your institution's subscription?
Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.
If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.
AccessPharmacy Full Site: One-Year Subscription
Connect to the full suite of AccessPharmacy content and resources including 30+ textbooks such as Pharmacotherapy: A Pathophysiologic Approach and Goodman & Gilman's The Pharmacological Basis of Therapeutics, high-quality videos, images, and animations, interactive board review, drug and herb/supplements databases, and more.
Pay Per View: Timed Access to all of AccessPharmacy
24 Hour Subscription $34.95
48 Hour Subscription $54.95
Pop-up div Successfully Displayed
This div only appears when the trigger link is hovered over.
Otherwise it is hidden from view.